Skip to content
Immunophotonics
  • About
    • Team
    • Board of Directors
    • Advisory Board
    • Highlighted Co-Inventor
    • Collaborators
  • Technology
  • Interventional Immuno-Oncology®
  • Clinical Trials
    • Colorectal Cancer (CRC)
    • Non-Small Cell Lung Cancer (NSCLC)
    • Melanoma
    • Soft Tissue Sarcoma (STS)
    • Hepatocellular Carcinoma (HCC)
    • Pancreatic Cancer
    • Vaccine Adjuvant
  • Patients
  • News & Media
  • Contact Us
Menu

News

404

News & Media

  •          
  • Print
Home » News & Media
Latest News

Immunophotonics to Attend CIRSE 2026 in Copenhagen

September 2, 2026
Robert Arch, PhD, and Tomas Hode, PhD, will connect with the global interventional oncology community September 5–9. Immunophotonics will attend…
Read More
Latest News Press Releases

Immunophotonics Announces Series C Financing and CEO Appointment Sept. 1, 2026

September 1, 2026
Immunophotonics, Inc. announced two important milestones supporting the company’s continued advancement of Interventional Immuno-Oncology®: the closing of more than $10…
Read More
Latest News

Immunophotonics Congratulates Professor Wei Chen on NIH Award

August 19, 2026
Immunophotonics congratulates Professor Wei Chen, co-inventor of IP-001 and a Co-Founder of Immunophotonics, Inc., on receiving an $11.5 million award…
Read More
Latest News Press Releases

Immunophotonics Expands Global IP Portfolio with China Patent Grant

June 16, 2026
Immunophotonics has strengthened its global intellectual property portfolio with the issuance of a patent by the China National Intellectual Property…
Read More
Latest News Press Releases

New IP-001 Clinical Data to Be Presented at ASCO Annual Meeting

May 19, 2026
Markus Joerger, M.D., Ph.D. will present new data from a multi-center Phase 1b/2a clinical trial of IP-001 at the American…
Read More
Latest News

Swiss Biotech Day, May 4-5, 2026

May 6, 2026
Immunophotonics Highlights IP-001 Development at Swiss Biotech Days. Dr. Theresa Visarius, Vice President of Business Development is sharing insights into…
Read More
Latest News

ECIO April 26–30, 2026

April 29, 2026
Robert, Theresa, and Tomas connecting with partners and peers at ECIO to discuss our work advancing IP-001, aimed at transforming…
Read More
Latest News

Shave to Save

March 25, 2026
On March 19, the Immunophotonics team was honored to take part in the Worldwide Technology American Cancer Society Shave to…
Read More
Latest News

Immunophotonics to Present at LSI USA ’26

March 12, 2026
Immunophotonics will participate in LSI USA ’26, held March 16–20, 2026, at the Waldorf Astoria Monarch Beach in Dana Point,…
Read More
Latest News

LSX Investival Showcase USA 2026 – March 10 & 11

March 4, 2026
Miguel Zubizarreta, CEO, and Robert Arch, President of Immunophotonics, Inc., are preparing to share key company updates and growth milestones…
Read More
1 2 3 … 14 Next »
Contact us for more info and updates
  • About
  • Team
  • Board of Directors
  • Advisory Board
  • Highlighted Co-Inventor
  • Collaborators
  • Technology
  • Clinical Trials
  • Colorectal Cancer (CRC)
  • Non-Small Cell Lung Cancer (NSCLC)
  • Melanoma
  • Soft Tissue Sarcoma (STS)
  • Hepatocellular Carcinoma (HCC)
  • Pancreatic Cancer
  • Vaccine Adjuvant
  • Patients
  • Background
  • Trial Summary

Quick Links

  • Interventional Immuno-Oncology®
  • News & Media
  • Careers
  • Contact Us
  • Privacy Policy
  • Site Map
© Immunophotonics, Inc. All Rights Reserved
Terms of Use | FCOI Policy
Website by Axxiem
Scroll to top